Immutep Limited Made Headway
Mon, May 05, 2025 at 07:43 PM
Immutep Limited (IMMP:NASDAQ) rocketted at $2.49, representing a gain of 45.6%. On Mon, May 05, 2025, IMMP:NASDAQ hit a New 2-Week High of $2.49. The stock appeared on our News Catalysts scanner on Mon, May 05, 2025 at 08:38 AM in the 'MERGER' category. From Mon, Apr 21, 2025, the stock recorded 70.00% Up Days and 54.55% Green Days
About Immutep Limited (IMMP:NASDAQ)
Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
Top 10 Gainers:
- Hyperscale Data Inc Com Par $ (GPUS:NYSEMKT), 465.69%
- N2OFF Inc. (NITO:NASDAQ), 140.28%
- NuCana plc (NCNA:NASDAQ), 130.66%
- SRAX, Inc. (SRAX:NASDAQ), 70.92%
- Nvni Group Limited (NVNI:NASDAQ), 52.99%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 51.64%
- Smart for Life Inc. (SMFL:NASDAQ), 50%
- Immutep Limited (IMMP:NASDAQ), 45.61%
- Color Star Technology Co. Ltd. (ADD:NASDAQ), 43.47%
- 22nd Century Group Inc (XXII:NASDAQ), 39.3%